ARTRON LABORATORIES INC

Artron Laboratories Inc. (est. 2002, Burnaby, British Columbia, CANADA) is a global frontrunner in in-vitro diagnostic lateral flow testing. Founded by a team of immunoassay experts, the company covers the full spectrum—from raw material R&D (monoclonal antibodies, membranes, buffers, antigens) to design, manufacturing, and technical support—making it a true one-stop IVD solutions provider.

The product lineup spans fertility hormones, infectious diseases, tumor and cardiac markers, food safety, GMOs, drugs of abuse, and

beyond. Specialties include lateral flow tests, chemiluminescence assays, ELISAs, and immuno-chip diagnostics.

Operating from over 200,000 ft² of facilities in the Greater Vancouver area, Artron is fully compliant with ISO 13485:2016, MDSAP, and GMP standards 

Artron rapid diagnostic products are regulated and licensed by Health Canada, FDA (510(k)), and bear the CE mark, plus additional approvals from agencies like the WHO.

The company is especially noted for its cost-effective vertical integration—controlling every manufacturing stage ensures quality, efficiency, and affordability .

R&D capabilities enable extensive custom and OEM services, such as bespoke lateral flow tests, components, and antibody/antigen solutions, all tailored to client needs.